Complexities of counseling women about HT

Andrew M. Kaunitz, MD

Dr. Kaunitz is Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville. He serves on the OBG MANAGEMENT Board of Editors.

Dr. Kaunitz receives grant or research support from Bayer, Agile, Noven, Teva, Endoceutics, and Medical Diagnostic Laboratories; is a consultant to Bayer and Merck; and owns stock in Becton Dickinson.

Andrew M. Kaunitz, MD

Dr. Kaunitz is Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville. He serves on the OBG MANAGEMENT Board of Editors.

Dr. Kaunitz receives grant or research support from Bayer, Agile, Noven, Teva, Endoceutics, and Medical Diagnostic Laboratories; is a consultant to Bayer and Merck; and owns stock in Becton Dickinson.

Andrew M. Kaunitz, MD

Dr. Kaunitz is Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville. He serves on the OBG MANAGEMENT Board of Editors.

Dr. Kaunitz receives grant or research support from Bayer, Agile, Noven, Teva, Endoceutics, and Medical Diagnostic Laboratories; is a consultant to Bayer and Merck; and owns stock in Becton Dickinson.